STACY DYCUS: Open Payments
NPI 1710529136 · CLARKSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,161 in 111 payments from 14 companies in 2025. Trend: 2023 $1,754 · 2024 $2,010 · 2025 $2,161
Food & beverage: $2,161
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $452 |
| E.R. Squibb & Sons, L.L.C. | 18 | $371 |
| Teva Pharmaceuticals USA, Inc. | 17 | $277 |
| Neurocrine BioSciences, Inc. | 8 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $190 |
| Janssen Pharmaceuticals, Inc | 13 | $186 |
| Otsuka America Pharmaceutical, Inc. | 7 | $133 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
| ABBVIE INC. | 5 | $79 |
| Noven Therapeutics, LLC | 3 | $59 |
Products named: ARISTADA, COBENFY, UZEDY, INGREZZA, CAPLYTA, INVEGA SUSTENNA, REXULTI, VRAYLAR.
Industry payments across TN — which companies pay providers there.
